Usta Engin, Renovanz Mirijam, Mustafi Migdat, Ziemer Gerhard, Aebert Hermann
Department of Thoracic-, Cardiac- and Vascular Surgery, Tübingen University Hospital, Germany.
J Cardiothorac Surg. 2010 Jan 18;5:3. doi: 10.1186/1749-8090-5-3.
After coronary artery bypass grafting ischemia/reperfusion injury inducing cardiomyocyte apoptosis may occur. This surgery-related inflammatory reaction appears to be of extreme complexity with regard to its molecular, cellular and tissue mechanisms and many studies have been performed on animal models. However, finding retrieved from animal studies were only partially confirmed in humans. To investigate this phenomenon and to evaluate possible therapies in vitro, adequate human cardiomyocyte models are required. We established a tissue model of human cardiomyocytes preserving the complex tissue environment. To our knowledge human cardiac tissue has not been investigated in an experimental setup mimicking extracorporeal circulation just in accordance to clinical routine, yet.
Cardiac biopsies were retrieved from the right auricle of patients undergoing elective coronary artery bypass grafting before cardiopulmonary bypass. The extracorporeal circulation was simulated by submitting the biopsies to varied conditions simulating cardioplegia (cp) and reperfusion (rep) in a microperfusion chamber. Cp/rep time sets were 20/7, 40/13 and 60/20 min. For analyses of the calcium homoeostasis the fluorescent calcium ion indicator FURA-2 and for apoptosis detection PARP-1 cleavage immunostaining were employed. Further the anti-apoptotic effect of carvedilol [10 microM] was investigated by adding into the perfusate.
Viable cardiomyocytes presented an intact calcium homoeostasis under physiologic conditions. Following cardioplegia and reperfusion a time-dependent elevation of cytosolic calcium as a sign of disarrangement of the calcium homoeostasis occurred. PARP-1 cleavage also showed a time-dependence whereas reperfusion had the highest impact on apoptosis. Cardioplegia and carvedilol could reduce apoptosis significantly, lowering it between 60-70% (p < 0.05).
Our human cardiac preparation served as a reliable cellular model tool to study apoptosis in vitro. Decisively cardiac tissue from the right auricle can be easily obtained at nearly every cardiac operation avoiding biopsying of the myocardium or even experiments on animals.The apoptotic damage induced by the ischemia/reperfusion stimulus could be significantly reduced by the cold crystalloid cardioplegia. The additional treatment of cardiomyocytes with a non-selective beta-blocker, carvedilol had even a significantly higher reduction of apoptotis.
冠状动脉搭桥术后可能会发生缺血/再灌注损伤,进而诱导心肌细胞凋亡。这种与手术相关的炎症反应在分子、细胞和组织机制方面似乎极其复杂,并且已经在动物模型上进行了许多研究。然而,从动物研究中获得的发现仅在人类中得到了部分证实。为了在体外研究这种现象并评估可能的治疗方法,需要合适的人类心肌细胞模型。我们建立了一个保留复杂组织环境的人类心肌组织模型。据我们所知,尚未在模拟体外循环的实验装置中按照临床常规对人类心脏组织进行研究。
在体外循环前,从接受择期冠状动脉搭桥手术的患者右心耳获取心脏活检组织。通过在微灌注室中将活检组织置于模拟心脏停搏(cp)和再灌注(rep)的不同条件下,模拟体外循环。cp/rep时间设置为20/7、40/13和60/20分钟。为分析钙稳态,使用荧光钙离子指示剂FURA-2,为检测凋亡,采用PARP-1裂解免疫染色。此外,通过向灌注液中添加卡维地洛[10微摩尔]来研究其抗凋亡作用。
存活的心肌细胞在生理条件下呈现完整的钙稳态。心脏停搏和再灌注后,细胞内钙随时间依赖性升高,这是钙稳态紊乱的标志。PARP-1裂解也显示出时间依赖性,而再灌注对凋亡的影响最大。心脏停搏和卡维地洛可显著降低凋亡,降低幅度在60 - 70%之间(p < 0.05)。
我们的人类心脏制剂可作为可靠的细胞模型工具用于体外研究凋亡。决定性的是,几乎在每次心脏手术时都能轻松从右心耳获取心脏组织,避免了对心肌进行活检甚至在动物身上进行实验。冷晶体心脏停搏可显著减少缺血/再灌注刺激诱导的凋亡损伤。用非选择性β受体阻滞剂卡维地洛对心肌细胞进行额外治疗,凋亡减少幅度甚至更高。